REGULATION OF SPHINGOMYELIN PATHWAY IN THE CORPUS LUTEUM
REGULATION OF SPHINGOMYELIN PATHWAY IN THE CORPUS LUTEUM
批准号:
6313353
负责人:
Bo R. RUEDA
金额:
$17.3万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-08 至 2001-11-30
关键词:
animal tissue apoptosis biological signal transduction ceramides corpus luteum cytokine cytotoxicity female gene expression interferon gamma mitogen activated protein kinase phosphodiesterases phosphorylation progesterone protooncogene pyrophosphatase second messengers sphingomyelin phosphodiesterase sphingomyelins steroid hormone biosynthesis tissue /cell culture transcription factor tumor necrosis factor alpha
中文摘要
黄体(CL)的主要功能是合成和
分泌孕酮,使子宫静止,
和维持妊娠。 任何功能的过早中断
黄体功能不全会导致妊娠失败,
周期性和生殖效率的降低。 的抑制
类固醇合成(功能回归),最终
破坏细胞内稳态(结构退化),
统称为黄体溶解。 最近,细胞因子
在黄体溶解中起积极作用;然而,
它们引起细胞毒活性的机制仍然是
演示。最近的证据表明,细胞死亡的信号,
无论是通过TNF α、IFN γ、FAS配体或其他应激相关的
刺激,通过鞘磷脂途径介导。巧合的是,这些
同样的因素也与类固醇的抑制和死亡有关
的CL。 细胞因子对酸性鞘磷脂酶的激活导致
神经酰胺水平升高 随后,应激诱导的神经酰胺被
据信优先通过细胞质应激发出信号
活化蛋白激酶(SAPK)是丝裂原活化的一员,
蛋白激酶级联反应(MAPKs)。 MAPK是细胞质酶
负责将细胞表面产生的信号
在细胞核中它们通过磷酸化
转录因子 我们假设,细胞因子,以及其他
细胞毒性刺激,将通过鞘磷脂启动细胞死亡
途径及其第二信使神经酰胺。 此外,委员会认为,
神经酰胺的随后增加将激活SAPKs,
最终磷酸化特定的转录因子,
细胞死亡,因此在从
类固醇生成的功能性抑制对
CL.为了解决这一假设,我们提出了以下目标:(1)
确定是否有特定的细胞因子参与调节
黄体退化的功能和结构方面激活了
鞘磷脂途径(2)描述对以下物质的多效性反应
细胞因子(TNF α-INF γ),如通过
ERK和/或SAPKs/JNK和(3)转录因子c-fos和c-jun
在黄体细胞中。(4)确定是否单独使用类固醇抑制
可以激活培养的牛黄体细胞中的鞘磷脂途径。
(5)确定半胱天冬酶在神经胺活化中的作用。 的
实验将利用牛黄体的明确的原代培养物
细胞,并采用互补的细胞和分子技术,
解决目标。 该项目有望提供新的信息
在黄体溶解过程中的细胞机制。
英文摘要
The primary function of the corpus luteum (CL) is to synthesize and
secrete progesterone to provide uterine quiescence for the establishment
and maintenance of pregnancy. Any premature disruption in the function
of the corpus luteum can result in a loss of pregnancy, irregular
cyclicity, and a reduction in reproductive efficiency. The inhibition
of steroid synthesis (functional regression), and the eventual
disruption of cellular homeostasis (structural regression), is
collectively described as luteolysis. More recently, cytokines have
been implicated in an active role in luteolysis; yet the exact
mechanisms by which they elicit their cytotoxic activity remains to be
demonstrated. Recent evidence suggests that the signal for cell death,
whether it be by TNFalpha, IFNgamma, FAS ligand or other stress-related
stimuli, is mediated via the sphingomyelin pathway. Coincedently, these
same factors have also been implicated in steroid inhibition and demise
of the CL. Activation of the acid-sphingomyelinase by cytokines results
in elevated ceramide levels. Subsequently, stress-induced ceramide is
believed to preferentially signal through the cytoplasmic stress
activated protein kinase (SAPK) a member of the mitogen activated
protein kinase cascade (MAPKs). MAPKs are cytoplasmic enzymes
responsible for translating the signal generated on the cell surface to
the nucleus where they regulate transcription by phosphorylating
transcription factors. We hypothesize that cytokines, as well as other
cytotoxic stimuli, will initiate cell death via the sphingomyelin
pathway and its second messenger ceramide in luteal cells. Furthermore,
subsequent increases in ceramide will activate SAPKs which will
ultimately phosphorylate specific transcription factors implicated in
cellular demise and therefore play a role in the transition from
functional inhibition of steroidogenesis to structural regression of the
CL. To address this hypothesis we have proposed the following aims: (1)
Determine if specific cytokines implicated in the regulation of the
functional and structural aspects of luteal regression activate the
sphingomyelin pathway. (2) Characterize the pleiotropic responses to
cytokines (TNFalpha-INFgamma) as determined by the relative changes in
ERKs and/or SAPKs/JNK and (3) the transcription factors c-fos and c-jun
in luteal cells. (4) Determine whether or not steroid inhibition alone
can activate the sphingomyelin pathway in cultured bovine luteal cells.
(5) Determine the role of capase enzymes in ceramine activation. The
experiments will utilize well defined primary cultures of bovine luteal
cells and employ complimentary cellular and molecular techniques to
address the aims. This project is expected to provide novel information
on the cellular mechanisms involved in the process of luteolysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cables role in endometrial differentiation and cancer
-
批准号:6679502
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:Bo R. RUEDA
-
依托单位:
Cables role in endometrial differentiation and cancer
-
批准号:7231023
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:Bo R. RUEDA
-
依托单位:
Cables role in endometrial differentiation and cancer
-
批准号:6784746
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:Bo R. RUEDA
-
依托单位:
Cables role in endometrial differentiation and cancer
-
批准号:7101809
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2003
-
负责人:Bo R. RUEDA
-
依托单位:
Cables role in endometrial differentiation and cancer
-
批准号:6919154
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:Bo R. RUEDA
-
依托单位:
Regulation of the sphingomyelin pathway in the CL
-
批准号:6544043
-
项目类别:
-
资助金额:$32.23万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
REGULATION OF SPHINGOMYELIN PATHWAY IN THE CORPUS LUTEUM
-
批准号:6125586
-
项目类别:
-
资助金额:$2.81万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
Regulation of the sphingomyelin pathway in the CL
-
批准号:6604912
-
项目类别:
-
资助金额:$29.98万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
Regulation of the sphingomyelin pathway in the CL
-
批准号:6748489
-
项目类别:
-
资助金额:$29.98万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
REGULATION OF SPHINGOMYELIN PATHWAY IN THE CORPUS LUTEUM
-
批准号:6329963
-
项目类别:
-
资助金额:$19.43万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
Regulation of the sphingomyelin pathway in the CL
-
批准号:6897138
-
项目类别:
-
资助金额:$29.98万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
REGULATION OF SPHINGOMYELIN PATHWAY IN THE CORPUS LUTEUM
-
批准号:2705109
-
项目类别:
-
资助金额:$16.64万
-
财政年份:1998
-
负责人:Bo R. RUEDA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: